Roche Weighs Divestment of Cancer Data Startup, FT Reports

--Roche is considering divesting or partially selling its U.S. cancer data specialist Flatiron Health, the Financial Times reports, citing unnamed sources.

--Flatiron's ownership by the Swiss pharma giant, although a separate legal entity, limited the startup's ability to partner with rivals and weighed on sales, according to the FT.

--Many Roche executives who initially supported the deal have left the company, resulting in reduced internal support for Flatiron, the FT reports.

-- Roche declined to comment when approached by Dow Jones Newswires.

Full story: https://bit.ly/4d7HPlk

Write to Helena Smolak at [e-mail]

(END) Dow Jones Newswires

08-07-24 0303ET